Abstracts tagged "corticosteroids and uveitis"

Abstract Number: 2273 • 2018 ACR/ARHP Annual Meeting
High Dose Intravenous Methylorednisolone Induces Rapid Improvement in Severe Non-Infectious Uveitis. a Multicenter Study of 120 Patients
Nuria Vegas-Revenga¹, Vanesa Calvo-Río¹, Íñigo González-Mazón², Lara Sánchez-Bilbao², Emma Beltrán³, Alejandro Fonollosa⁴, Olga Maiz-Alonso⁵, Ana Blanco⁶, Miguel Cordero-Coma⁷, Norberto Ortego Centeno⁸, Ignacio Torre-Salaberri⁹, Félix Francisco¹⁰, Santiago Muñoz-Fernández¹¹, Maria del Mar Esteban Ortega¹², Manuel Díaz-Llopis¹³, Mario Agudo², Joaquin Cañal¹, Juan Antonio Ventosa¹, Rosalía Demetrio-Pablo¹, Lucia C. Domínguez-Casas¹, Miguel Angel González-Gay¹⁴ and Ricardo Blanco², ¹Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ²Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ³Rheumatology, Hospital General Universitario de Valencia. Spain, Valencia, Spain, ⁴Ophthalmology, Hospital de Cruces. Bilbao. Spain, Bilbao, Spain, ⁵Hospital Universitario Donostia. San Sebastian. Spain, Donostia, Spain, ⁶Ophtamology, Hospital Universitario Donostia. San Sebastian. Spain, San Sebastian, Spain, ⁷Ophthalmology, Hospital de León. Spain, León, Spain, ⁸Medicine Department, Hospital Universitario San Cecilio. Granada. Spain, Granada, Spain, ⁹Rheumatology, Hospital Universitario de Basurto. Bilbao. Spain, Bilbao, Spain, ¹⁰Rheumatology, Hospital Doctor Negrín. Las Palmas de Gran Canaria. Spain, Las Palmas de Gran Canaria, Spain, ¹¹Hospital Universitario Infanta Sofia. Madrid. Spain, Mardid, Spain, ¹²Hospital Universitario Infanta Sofia. Madrid. Spain, Madrid, Spain, ¹³Hospital Universitario La Fe. Valencia. Spain, Valencia, Spain, ¹⁴Rheumatology. Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain
Background/Purpose: In uveitis rapid and effective remission-inducing therapy is mandatory to avoid irreversible structural and functional damage.Our aim was to evaluate the efficacy and safety…
Abstract Number: 1963 • 2017 ACR/ARHP Annual Meeting
Association of Corticosteroid Exposure with Ophthalmologic Complications and Systemic Adverse Events in Non-Infectious Uveitis Patients Using Administrative Claims in the United States
Nisha Acharya¹, Keith A. Betts², Oscar Patterson-Lomba², Arijit Ganguli³, Sophie Schonfeld² and Jenny Griffith³, ¹University of California San Francisco, San Francisco, CA, ²Analysis Group, Inc., Boston, MA, ³AbbVie Inc., North Chicago, IL
Background/Purpose: Noninfectious uveitis (NIU) is a collection of intraocular inflammatory disorders associated with significant visual impairment. Corticosteroids (CS) are typically the first-line drug therapy for…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].